마이코톡신 검사 및 제염 시장 기회, 성장 촉진요인, 업계 동향 분석 및 예측(2026-2035년)

The Global Mycotoxin Testing & Decontamination Market was valued at USD 4.4 billion in 2025 and is estimated to grow at a CAGR of 5.8% to reach USD 7.8 billion by 2035.

Growth is shaped by stricter regulatory frameworks, expanding international food trade, and heightened awareness of fungal toxin risks across supply chains. Mycotoxin testing plays a critical role in identifying hazardous compounds such as aflatoxins in food and animal feed, using advanced analytical techniques including chromatography, immunoassays, and rapid detection kits. A notable market shift is the rising preference for on-site and rapid testing systems that integrate prevention, monitoring, and control functions within unified workflows. This transition is improving food safety assurance, reducing financial losses from contamination events, and strengthening regulatory compliance while enhancing transparency across supply networks. In feed applications, decontamination solutions support livestock health and productivity, while in food processing, continuous monitoring safeguards consumer safety and export eligibility. A key structural change is the transition from optional testing practices to mandatory, accredited compliance systems in several major jurisdictions, which is significantly reinforcing baseline demand. Regulatory expansion has also widened contaminant monitoring scopes to include additional fungal metabolites while tightening permissible limits in sensitive food categories, further intensifying testing requirements globally.

The mycotoxin decontamination segment was valued at USD 2.8 billion in 2025. This segment is largely driven by feed additive and binder solutions that include clay-based materials, activated carbon, yeast-derived cell wall components, and hydrated sodium calcium aluminosilicates. These solutions align with the large-scale, cost-sensitive operational model of the global compound feed industry, where efficiency and broad-spectrum toxin binding capability are essential performance requirements.

The decontamination methods segment accounted for a 66.8% share in 2025. Innovation within this segment is increasingly focused on biological and sustainable approaches, including enzyme-driven detoxification systems and microbial-based solutions that are gradually replacing traditional chemical treatments. The use of multi-functional binders and integrated toxin risk management platforms is becoming more widespread. At the same time, the integration of precision agriculture tools and post-harvest monitoring technologies is strengthening preventive strategies, reflecting a broader shift toward end-to-end mycotoxin risk management across the agricultural value chain.

North America Mycotoxin Testing & Decontamination Market is expected to reach USD 2 billion by 2035, supported by its well-established regulatory environment and mature food safety infrastructure. The region is characterized by stringent oversight from agencies such as the FDA and USDA, which continues to drive consistent adoption of advanced analytical testing methods. The United States remains the primary contributor, with strong awareness among food producers, grain processors, and feed manufacturers ensuring steady demand across the entire supply chain.

Major companies operating in the global mycotoxin testing & decontamination industry include Eurofins Scientific SE, Neogen Corporation, SGS SA, Intertek Group plc, Bureau Veritas SA, ALS Limited, Romer Labs (ERBER Group), Merieux NutriSciences, DSM-Firmenich (Biomin), Alltech Inc., Kemin Industries Inc., Olmix Group SAS, and Charm Sciences Inc. Companies in the mycotoxin testing & decontamination market are prioritizing expansion of rapid and on-site testing solutions that reduce turnaround time and improve supply chain responsiveness. Many players are investing in advanced analytical platforms that integrate chromatography, immunoassay, and digital reporting capabilities for higher accuracy and regulatory compliance. Strategic collaborations with food producers and feed manufacturers are being strengthened to embed testing and decontamination solutions directly into production workflows. Firms are also focusing on biological and enzyme-based detoxification technologies to align with sustainability trends and reduce reliance on chemical treatments.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Offering type
  • 2.2.2 Technology & method
  • 2.2.3 Mycotoxin type
  • 2.2.4 End use industry
  • 2.2.5 Regional
• 2.3 TAM Analysis, 2026-2035
• 2.4 CXO perspectives: Strategic imperatives
• 2.5 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Profit margin
  • 3.1.3 Value addition at each stage
  • 3.1.4 Factor affecting the value chain
  • 3.1.5 Disruptions
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
  • 3.2.2 Industry pitfalls and challenges
  • 3.2.3 Market opportunities
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East & Africa
• 3.5 Porter's analysis
• 3.6 PESTEL analysis
• 3.7 Technology and innovation landscape
  • 3.7.1 Current technological trends
  • 3.7.2 Emerging technologies
• 3.8 Price trends
  • 3.8.1 By region
  • 3.8.2 By tag technology
• 3.9 Future market trends
• 3.10 Patent landscape
• 3.11 Trade statistics (HS code)
  • 3.11.1 Major importing countries
  • 3.11.2 Major exporting countries
• 3.12 Sustainability and environmental aspects
  • 3.12.1 Sustainable practices
  • 3.12.2 Waste reduction strategies
  • 3.12.3 Energy efficiency in production
  • 3.12.4 Eco-friendly initiatives
• 3.13 Carbon footprint consideration

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 By region
    • 4.2.1.1 North America
    • 4.2.1.2 Europe
    • 4.2.1.3 Asia Pacific
    • 4.2.1.4 LATAM
    • 4.2.1.5 MEA
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Offering Type, 2022-2035 (USD Billion) (Million Test)

• 5.1 Key trends
• 5.2 Mycotoxin testing
  • 5.2.1 Testing products
    • 5.2.1.1 Instruments & equipment
    • 5.2.1.2 Test kits & reagents
    • 5.2.1.3 Consumables & accessories
  • 5.2.2 Testing services
    • 5.2.2.1 In-house laboratory testing
    • 5.2.2.2 Contract testing services
• 5.3 Mycotoxin decontamination
  • 5.3.1 Decontamination products
    • 5.3.1.1 Feed additives & binders
    • 5.3.1.2 Chemical detoxification agents
    • 5.3.1.3 Biological/enzymatic detoxifiers
  • 5.3.2 Decontamination systems & equipment
    • 5.3.2.1 Physical treatment systems
    • 5.3.2.2 Industrial decontamination systems

Chapter 6 Market Estimates and Forecast, By Technology & Method, 2022-2035 (USD Billion) (Million Test)

• 6.1 Key trends
• 6.2 Testing Technologies
  • 6.2.1 Chromatography-based
    • 6.2.1.1 HPLC
    • 6.2.1.2 LC-MS/MS
    • 6.2.1.3 GC-MS
    • 6.2.1.4 HRMS
  • 6.2.2 Immunoassay-based
    • 6.2.2.1 ELISA
    • 6.2.2.2 Radioimmunoassay (RIA)
    • 6.2.2.3 FPIA
  • 6.2.3 Lateral Flow Assay-based
    • 6.2.3.1 Quantitative LFA
    • 6.2.3.2 Qualitative/Semi-Quantitative Strip Tests
  • 6.2.4 Spectroscopy-based
    • 6.2.4.1 Near-Infrared (NIR)
    • 6.2.4.2 FTIR
    • 6.2.4.3 Fluorescence Spectroscopy
  • 6.2.5 Biosensor-based
    • 6.2.5.1 Electrochemical Biosensors
    • 6.2.5.2 Optical Biosensors
    • 6.2.5.3 Nano-Material Enhanced
• 6.3 Decontamination methods
  • 6.3.1 Physical methods
    • 6.3.1.1 Thermal treatment
    • 6.3.1.2 UV irradiation
    • 6.3.1.3 Ozone treatment
    • 6.3.1.4 Gamma irradiation
  • 6.3.2 Chemical methods
    • 6.3.2.1 Ammoniation & alkali treatment
    • 6.3.2.2 Organic acid treatment
    • 6.3.2.3 Oxidizing agent treatment
  • 6.3.3 Biological & enzymatic methods
    • 6.3.3.1 Microbial biotransformation
    • 6.3.3.2 Enzymatic degradation agents
    • 6.3.3.3 Probiotic-based detoxification
  • 6.3.4 Adsorption-based methods
    • 6.3.4.1 Clay minerals
    • 6.3.4.2 Activated carbon binders
    • 6.3.4.3 Yeast cell wall extract
    • 6.3.4.4 HSCAS

Chapter 7 Market Estimates and Forecast, By Mycotoxin Type, 2022-2035 (USD Billion) (Million Test)

• 7.1 Key trends
• 7.2 Aflatoxins
  • 7.2.1 Aflatoxin B1
  • 7.2.2 Aflatoxin B2
  • 7.2.3 Aflatoxin G1
  • 7.2.4 Aflatoxin G2
  • 7.2.5 Aflatoxin M1 (Dairy)
• 7.3 Ochratoxins
  • 7.3.1 Ochratoxin A (OTA)
  • 7.3.2 Ochratoxin B (OTB)
• 7.4 Fumonisins
  • 7.4.1 Fumonisin B1 & B2
  • 7.4.2 Fumonisin B3
• 7.5 DON & Trichothecenes
  • 7.5.1 Deoxynivalenol (DON/Vomitoxin)
  • 7.5.2 T-2 & HT-2 Toxins
  • 7.5.3 Diacetoxyscirpenol (DAS)
• 7.6 Zearalenone (ZEA)
• 7.7 Patulin
• 7.8 Ergot Alkaloids
• 7.9 Others

Chapter 8 Market Estimates and Forecast, By End Use Industry, 2022-2035 (USD Billion) (Million Test)

• 8.1 Key trends
• 8.2 Food & beverages
  • 8.2.1 Cereals, grains & pulses
  • 8.2.2 Nuts & dried fruits
  • 8.2.3 Spices & herbs
  • 8.2.4 Dairy & dairy products
  • 8.2.5 Beverages (beer/wine/juice)
  • 8.2.6 Processed & packaged foods
  • 8.2.7 Meat & poultry
• 8.3 Animal feed
  • 8.3.1 Poultry feed
  • 8.3.2 Swine feed
  • 8.3.3 Ruminant feed
  • 8.3.4 Aquaculture feed
  • 8.3.5 Pet food
• 8.4 Agriculture & grain
  • 8.4.1 Grain elevators & post-harvest storage
  • 8.4.2 Commodity trading & export inspection
  • 8.4.3 Seed & oilseed processing
• 8.5 Pharmaceuticals
  • 8.5.1 Drug formulation & raw material qc
  • 8.5.2 Herbal & botanical products
  • 8.5.3 Nutraceutical & dietary supplement
• 8.6 Environmental testing
  • 8.6.1 Soil & agricultural land surveillance
  • 8.6.2 Water quality monitoring
  • 8.6.3 Indoor air & occupational exposure

Chapter 9 Market Estimates and Forecast, By Region, 2022-2035 (USD Billion) (Million Test)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Alltech Inc.
• 10.2 ALS Limited
• 10.3 Bureau Veritas SA
• 10.4 Charm Sciences Inc.
• 10.5 DSM-Firmenich (Biomin)
• 10.6 Eurofins Scientific SE
• 10.7 Intertek Group plc
• 10.8 Kemin Industries Inc.
• 10.9 Merieux NutriSciences
• 10.10 Neogen Corporation
• 10.11 Olmix Group SAS
• 10.12 Romer Labs (ERBER Group)
• 10.13 SGS SA